Does Dr. ANKUR JAIN have financial conflicts of interest?

Dr. ANKUR JAIN (MD) has received a total of $3,714 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,714 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ANKUR JAIN?

According to CMS Open Payments data, Dr. ANKUR JAIN received funding from TAKEDA PHARMACEUTICALS U.S.A ($582), ABBVIE ($546), and INTERCEPT PHARMACEUTICALS ($374).

Does Dr. ANKUR JAIN receive research grants or speaking fees?

Dr. ANKUR JAIN has received $3,714 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ANKUR JAIN

MDReal-Time Hydrated

Specialty: Internal Medicine, Gastroenterology

Practice Location: HONOLULU, HI 96817

NPI Number: 1306866207

LIFETIME INDUSTRY VALUE

$3,714

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. JAIN is a verified Internal Medicine, Gastroenterology practitioner based in HONOLULU, HI.

Between 2021 and 2024, Dr. JAIN had an overall industry promotional and research financial footprint of $3,714 as recorded in the federal CMS Open Payments database.

$3,714 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. JAIN's primary funding source is TAKEDA PHARMACEUTICALS U.S.A, which accounts for $582 (representing 15.7% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

TAKEDA PHARMACEUTICALS U.S.A

Rank 1

$582

15.7%

ABBVIE

Rank 2

$546

14.7%

INTERCEPT PHARMACEUTICALS

Rank 3

$374

10.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.